A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: Summary and conclusions

British Journal of Cancer

Volumn 83, Issue 5, 2000, Pages 561-565

  Cuzick, J ^a   Sasieni, P ^a   Davies, P ^b   Adams, J ^a   Normand, C ^d   Frater, A ^d   Van Ballegooijen, M ^c   Van Den Akker Van Marle, E ^a,c  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b Lakeside Suite   (United Kingdom)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d NONE

Author keywords

Cervical screening; HPV testing; Systematic review

Indexed keywords

ARTICLE; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0033868974     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1375     Document Type: Article

References (39)

1. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802
2. Burger MP, Hollema H, Pieters WJ et al (1996) Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer 73: 831-836
3. Clavel C, Masure M, Bory JP et al (1999) Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80: 1306-1311
4. Cox JT, Lorincz AT, Schiffman MH et al (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172: 946-954
5. Cuzick J, Szarewski A, Terry G et al (1995) Human papillomavirus testing in primary cervical screening. Lancet 345: 1533-1537
6. Cuzick J, Beverley E, Ho L et al (1999a) HPV testing in primary screening of older women. Br J Cancer 81: 554-558
7. Cuzick J, Sasieni P, Davies P et al (1999b) A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 3(14): 1-204
8. Cuzick J, Terry G, Ho L et al (2000) Association between high risk HPV types, HLA DRB1 * and DQB1 * alleles and cervical cancer in British women. Br J Cancer 82: 1348-1352
9. de Roda Husman AM, Snijders PJ, Stel HV et al (1995) Processing of long stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72: 412-417
10. Dillner J, Lehtinen M, Bjorge T et al (1997) Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89: 1293-1299
11. Habbema JDF, Oortmarssen GJ van, Lubbe JThN et al (1984) The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs in Biomed 20: 79-93
12. Herrero R, Hildesheim A, Bratti C et al (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464-474
13. Herrington CS, Evans MF, Hallam NF et al (1995) Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities. Br J Cancer 71: 206-209
14. Hill R, Kuhn L, Denny L et al (eds) (1999) Use of HPV DNA testing for cervical cancer screening: Results from the Khayelitsha Study, South Africa. In: 17th International Papillomavirus Conference, Charleston, South Carolina
15. Ho GY, Burk RD, Klein S et al (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365-1371
16. IARC Working Group on the Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 293: 659-664
17. IARC (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 64. Human papillomaviruses. International Agency for Research on Cancer: Lyon
18. ICRF Coordinating Committee on Cervical Screening (1984) Organisation of a programme for cervical cancer screening. Br Med J 289: 894-895
19. ICRF Co-ordinating Committee on Cervical Screening (1986) The management of a cervical screening programme: a statement (October 1985). Community Medicine 3: 179-184
20. Kjaer SK and Brinton LA (1993) Adenocarcinomas of the cervix: the epidemiology of an increasing problem. Epidemiol Rev 15: 486-498
21. Kjellberg L, Wiklund F, Sjöberg I et al (1998) A population-based study of human papillomavirus deoxybribonucleic acid testing for predicting cervical intraepithelial neoplasia. Am J Obstet Gynecol 179: 497-502
22. Kruger-Kjaer S, van den Brule AJ, Svare El et al (1998) Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer 76: 613-619
23. Lehtinen M, Dillner J, Knekt P et al (1996) Serologically diagnosed infection and human papillomavirus type 16 and risk tor subsequent development of cervical carcinoma: nested case-control study. Br Med J 312: 537-539
24. Manns MM, Wright DK, Lewis AJ et al (1989) The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Molecular Diagnostics of Human Cancer, Cancer Cells 7, Furth M and Greaves M (eds), pp. 209-214. Cold Spring Harbor Press, NY
25. Manos MM, Kinney WK, Hurley LB et al (1999) Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281: 1605-1610
26. Nobbenhuis MAE, Walboomers JMM, Helmerhorst TJM et al (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20-25
27. Olsen AO, Gjoen K, Sauer T et al (1995) Human papillomavirus and cervical intraepithelial neoplasia grade II/III: a population based case-control study. Int J Cancer 61: 312-315
28. Peyton CL, Schiffman M, Lorincz AT et al (1998) Comparison of PCR and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36: 3248-3254
29. Raffle AE, Alden B and Mackenzie EF (1995) Detection rates for abnormal cervical smears: what are we screening for? Lancet 345: 1469-1473
30. Reid R, Greenberg MD, Lorincz A et al (1991) Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?. Am J Obstet Gynecol 164: 1461-1471
31. Remmink AJ, Walboomers JM, Helmerhorst TJ et al (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311
32. Sasieni P, Cuzick J and Farmery E (1995) Accelerated decline in cervical cancer mortality in England and Wales. Lancet 346: 1566-1567
33. Sasieni PD, Cuzick J, Lynch-Farmery E and the NCN Working Group (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer 73: 1001-1005
34. Solomon D, Schiffman M, Tarone R for the ALTS Group. Comparison of HPV testing, cytology and immediate colposcopy in ASCUS triage: baseline review from randomized trial (ALTS). J Natl Cancer Inst (submitted)
35. Shafi MI (1994) Cytological surveillance avoids treatment. Br Med J 309: 590-591
36. Vizcaino AP, Moreno V, Bosch FX et al (1998) International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75: 536-545
37. Walboomers JM, Husman AM, Snijders PJ et al (1995) Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48: 728-732
38. Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
39. Wright TC, Denny L, Kuhn L et al (2000) HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283: 81-86